דייליפורט 0.5 מ"ג - Dailiport 0.5 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	××××××¤××¨× 1 ×"× - Dailiport 1 mg ××××××¤××¨× 3 ×"× - Dailiport 3 mg ××××××¤××¨× 5 ×"× - Dailiport 5 mg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	L04AD Calcineurin inhibitors
××¨××× ×¤×¢×× (ATC5)	Â Tacrolimus AS MONOHYDRATE 0.5 MG âL04AD02
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	×§×¤×¡××××ª ××©××¨××¨ ××××©×, CAPSULES PROLONGED RELEASE ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.12.2023 Patient information leaflet â31.12.2023 ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.12.2023

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××××××¤××¨× 0.5 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	LEK PHARMACEUTICALS D.D., SLOVENIA
×©× ××¢× ××¨××©××	SANDOZ PHARMACEUTICALS ISRAEL LTD
×¨××©×××	×ª××¨×× ×××©×: 1/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	19/06/2025

השינוי האחרון נעשה בֹ־19 ביוני 2025 ב־10:25